Japan· JP-3222007G1033
硫酸鉄水和物
A medicinal product containing 硫酸鉄水和物, registered in Japan by ヴィアトリス製薬, on the national reimbursement list.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- 硫酸鉄水和物
- Manufacturer
- ヴィアトリス製薬
- Country
- Japan (JP)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
硫酸鉄水和物 in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomActiFerr-S 200mg tabletsMaN Pharma Ltd
- PolandObsidanInPharm Sp. z o.o.
- United StatesFerrous SulfateRichmond Pharmaceuticals Inc.
- BelgiumFero-Gradumet 525 mgTeofarma
- FranceFER AP-HP 0,5 mg NOUVEAU-NE, géluleASSISTANCE PUBLIQUE - HOPITAUX DE PARIS - AP-HP
- NorwayDuroferonPerrigo Sverige AB
- FinlandMicroferPfizer Health Ab
- GermanyEisensulfat LomapharmLomapharm Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Austria · Ferro - Gradumet
- Belgium · Fero-Gradumet
- Germany · Eisensulfat Lomapharm, Ferro Aiwa
- Spain · Ferogradumet
- France · Fer Nouveau-Ne Ap-Hp
- United Kingdom (Northern Ireland) · Feospan, Ferrous Sulfate Wockhardt Uk
- Greece · Tardyferon
- Hungary · Ferro-Gradumet
- Lithuania · Tardyferon
- Luxembourg · Fero-Gradumet
- Norway · Duroferon, Ferromax
- Portugal · Ferro-Gradumet
- Slovakia · Tardyferon
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bdbdec81-3540-4175-86bf-d58ef87d3c5c GET /v1/drugs/bdbdec81-3540-4175-86bf-d58ef87d3c5c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "１０５ｍｇ１錠",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "3222007G1033",
"category": "内用薬",
"price_yen": 6.3,
"generic_name": "硫酸鉄水和物",
"product_name_jp": null,
"therapeutic_class": "3222",
"transitional_expiry": null
}See everything about 硫酸鉄水和物.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.